Novel Coronavirus R&D | NLM

Disaster Information Management Research Center | NLM

Novel Coronavirus R&D

01/28/2020 12:00 AM EST

Source: World Health Organization (WHO). Published: 1/28/2020. As part of the World Health Organization’s response to the 2019 novel coronavirus (2019-nCoV) outbreak, the R&D Blueprint has been activated to accelerate diagnostics, vaccines, and therapeutics for this novel coronavirus. This web page provides links to the latest reports about vaccines, therapeutics, and diagnostics from the Scientific Advisory Group and Global Coordination Mechanism. (Text)